Related Experiment Video
Updated: Mar 7, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
Immunotherapy in ovarian cancer
Venkatesh Krishnan1, Jonathan S Berek2, Oliver Dorigo2
1Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California.
Immunotherapy shows promise for ovarian cancer by combining treatments to boost the immune system and overcome local suppression. Further research into combination strategies and biomarkers is crucial for effective treatment.
Area of Science:
- Oncology
- Immunology
- Cancer Therapeutics
Background:
- Current ovarian cancer treatments remain inadequate despite advances in chemotherapy.
- Ovarian tumors present unique challenges due to local immune suppression.
- Immunotherapy offers a novel and promising therapeutic avenue for ovarian cancer.
Purpose of the Study:
- To review current and emerging immunotherapeutic approaches for ovarian cancer.
- To highlight the potential of combination immunotherapy strategies.
- To emphasize the importance of biomarker discovery in immunotherapy.
Main Methods:
- Review of preclinical and clinical data on various immunotherapeutic modalities.
- Discussion of antibody-based therapies.
- Analysis of immune checkpoint blockade, cancer vaccines, and chimeric antigen receptor (CAR)-T cell therapies.
Main Results:
- Multiple immunotherapeutic modalities have shown preclinical success.
- Several approaches, including antibody therapies and CAR-T cells, have entered clinical trials.
- Combination strategies are essential for overcoming treatment resistance and enhancing efficacy.
Conclusions:
- Immunotherapy represents a significant advancement in ovarian cancer treatment.
- Combining different immunotherapeutic approaches can augment anti-tumor immunity and prevent immune suppression.
- Biomarker discovery is critical for personalizing and optimizing immunotherapy for ovarian cancer patients.
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
07:59Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
Published on: December 5, 2020
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...